RenovoRx, Inc. financial data

Symbol
RNXT on Nasdaq
Location
333 W. Santa Clara Street, Suite 900, San Jose, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 171 % +271%
Return On Equity -403 % -91.5%
Return On Assets -149 % -3.32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24M shares +124%
Common Stock, Shares, Outstanding 24M shares +124%
Entity Public Float 15.5M USD 0%
Common Stock, Value, Issued 2K USD +100%
Weighted Average Number of Shares Outstanding, Basic 24M shares +126%
Weighted Average Number of Shares Outstanding, Diluted 24M shares +126%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.2M USD +6.51%
General and Administrative Expense 5.07M USD -16.7%
Operating Income (Loss) -10.3M USD +6.36%
Nonoperating Income (Expense) 2.16M USD +97.7%
Net Income (Loss) Attributable to Parent -8.11M USD +17.9%
Earnings Per Share, Basic -0.58 USD/shares +44.8%
Earnings Per Share, Diluted -0.58 USD/shares +54.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.7M USD +97.2%
Marketable Securities, Current 2.05M USD
Cash, Cash Equivalents, and Short-term Investments 6.4M USD
Assets, Current 7.27M USD -55.4%
Assets 12M USD +90.1%
Accounts Payable, Current 438K USD -49.8%
Accrued Liabilities, Current 873K USD +5.56%
Liabilities, Current 1.31M USD -22.8%
Liabilities 2.73M USD -46.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 17K USD
Retained Earnings (Accumulated Deficit) -44.9M USD -22.1%
Stockholders' Equity Attributable to Parent 9.27M USD +680%
Liabilities and Equity 12M USD +90.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.2M USD +18.6%
Net Cash Provided by (Used in) Financing Activities 5.42M USD +90233%
Net Cash Provided by (Used in) Investing Activities 2.03M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 24M shares +124%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.22M USD
Deferred Tax Assets, Valuation Allowance 12.7M USD +43.5%
Deferred Tax Assets, Gross 12.7M USD +43.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.39M USD -2.66%
Deferred Tax Assets, Operating Loss Carryforwards 8.87M USD +36.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares
Unrecognized Tax Benefits 646K USD +43.9%
Additional Paid in Capital 54.1M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 18K USD
Share-based Payment Arrangement, Expense 239K USD +67.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares